Benzinga
Benzinga
Benzinga
sábado, septiembre 19

Chimera Investment Corp

CIMNYSE
Trade with Public
Trade with Public
$10.87
-0.13-1.18%
al cierre: Sep 18, 5:00 PM EST
$10.90
0.030.28%
After hour: Sep 18, 5:40 PM EST
Dividendo: La fecha límite del dividendo es dentro de 11 días
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Chimera Investment Analyst Price Targets

Wall Street analyst price targets and consensus rating for Chimera Investment (CIM).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1Buy
3Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$15Upside to Avg. PT+33.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Aug 6, 2026Keefe, Bruyette & WoodsBose GeorgePT CutMarket Perform$15→$14
Jun 3, 2026RBC CapitalKenneth S. LeeMaintainedSector Perform$14
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $15 to $14.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

Investors seek dividend-yielding stocks during market turbulence. Benzinga provides latest analyst ratings and accurate analysts for high-yield stocks in finance.
Avi Kapoor

PRO
RBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

RBC Capital analyst Kenneth S. Lee reiterates Chimera Investment (NYSE:CIM) with a Sector Perform and maintains $14 price target.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields

Avi Kapoor

PRO
UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.
Benzinga Newsdesk

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $16.5 to $15.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved